Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Statement re Offer for Subscription

30 Apr 2014 07:01

RNS Number : 8464F
Maven Income & Growth VCT 4 PLC
30 April 2014
 



Maven Income and Growth VCT 4 plc (the "Company")

 

Extension to Offer for Subscription

 

On 24 October 2013, the Company, Maven Income and Growth VCT plc, Maven Income and Growth VCT 2 plc, Maven Income and Growth VCT 3 plc, Maven Income and Growth VCT 5 plc and Maven Income and Growth VCT 6 plc (together "the Companies") announced that they had published a Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares in each of the Companies to raise, in aggregate, up to £20 million (before issue costs) together with an over-allotment facility for up to a further £5 million, in aggregate (the "Offer").

 

The Offer closed on 5 April 2014 in relation to the tax year 2013/14 and was intended to close on 30 April 2014 in relation to the tax year 2014/15 unless fully subscribed by an earlier date or previously extended by the directors of the Company (the "Directors") to no later than 30 September 2014.

 

The Finance Bill 2014 (the "Bill"), published on 27 March 2014, contained proposed changes to regulations which would apply to VCT shares issued on or after 6 April 2014. The Directors have been advised that certain provisions of the Bill are ambiguous and, if an allotment were to be made subsequent to 6 April 2014, could be interpreted in a manner that would have serious and adverse tax consequences for all Shareholders. Although HM Treasury have acknowledged the concerns made by the VCT industry regarding these provisions, and have agreed that amendments will be made to them, the relevant amendments have not yet been published. Any amendments will also be subject to Parliamentary review and debate.

 

Therefore, in the interest of all of the Company's Shareholders, the Directors have decided to postpone any allotment of new Ordinary Shares under the Offer for the 2014/15 tax year, with applications (and application monies) held pending until the Directors believe that there is certainty that allotments can take place without contravening the new rules. At such time when the Directors have been advised that the allotments can be made without adverse effects on the status and operation of the Company, an appropriate announcement will be made.

 

Given that the Directors intended to allot Ordinary Shares for the tax year 2014/15 before the end of April 2014, it was the expectation that all new investors under the Offer would be eligible to receive the final dividend from the Company for the year ended 31 December 2013. However, in view of the above, it is possible that any further allotment of new Ordinary Shares may now take place after the record date for this dividend, in which case the Offer Price will be adjusted under the Pricing Formula for the Offer and will reflect that no dividend payment will be received.

 

In view of the above, the Offer has been extended to 5.00 pm on 30 September 2014 or such earlier date on which the Offer is fully subscribed or on which the directors of the Companies may resolve to close the Offer. In relation to this issue, it is also proposed that a Supplementary Prospectus will be submitted to the UKLA for approval, at which point a further announcement will be made.

 

Any enquiries in respect of this extension to the Offer should be directed to:

 

Maven Capital Partners UK LLP:

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

30 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEPGUBPCUPCPGB
Date   Source Headline
20th May 202210:03 amRNSIssue of Equity
13th May 20223:24 pmRNSStatement re Dividend Investment Scheme
12th May 20223:19 pmRNSNet Asset Value(s)
11th May 20222:01 pmRNSResult of AGM & Directorate Change
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
22nd Mar 20223:23 pmRNSAnnual Financial Report
16th Mar 20223:32 pmRNSTransaction in Own Shares
15th Mar 20223:09 pmRNSTransaction in Own Shares
11th Mar 202211:41 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
10th Mar 202211:04 amRNSNet Asset Value and Proposed Final Dividend
18th Feb 20225:32 pmRNSIssue of Equity - Replacement Announcement
7th Feb 202212:49 pmRNSDirector/PDMR Shareholding
7th Feb 202212:48 pmRNSDirector/PDMR Shareholding
7th Feb 202210:51 amRNSIssue of Equity
4th Feb 20229:46 amRNSNet Asset Value(s)
31st Jan 20224:25 pmRNSStatement re Offer for Suscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
2nd Dec 20213:37 pmRNSTransaction in Own Shares
11th Nov 20213:25 pmRNSNet Asset Value(s)
20th Oct 20214:44 pmRNSResult of General Meeting
1st Oct 20219:22 amRNSIssue of Equity
28th Sep 20213:22 pmRNSStatement re Dividend Investment Scheme
20th Sep 20215:42 pmRNSStatement re Change of Registrar
20th Sep 20215:21 pmRNSPublication of a Prospectus
7th Sep 20214:47 pmRNSTransaction in Own Shares
31st Aug 20213:27 pmRNSTransaction in Own Shares
27th Aug 20213:23 pmRNSHalf-year Report
24th Aug 20213:42 pmRNSTransaction in Own Shares
23rd Aug 20213:14 pmRNSTransaction in Own Shares
19th Aug 20213:04 pmRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
24th May 20214:45 pmRNSTransaction in Own Shares
21st May 202111:02 amRNSIssue of Equity
17th May 20214:32 pmRNSStatement re Dividend Investment Scheme
12th May 20214:08 pmRNSNet Asset Value(s)
12th May 202112:37 pmRNSResult of AGM
9th Apr 20215:48 pmRNSAnnual Financial Report
24th Feb 20214:20 pmRNSTransaction in Own Shares
23rd Feb 20214:18 pmRNSTransaction in Own Shares
17th Feb 20214:37 pmRNSStatement re NAV and Final Dividend
8th Dec 20203:27 pmRNSTransaction in Own Shares
17th Nov 20204:26 pmRNSTransaction in Own Shares
16th Nov 20204:52 pmRNSTransaction in Own Shares
11th Nov 20205:01 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.